⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL456665 | 0.77 | — | — | |
| SCHEMBL12825534 | 0.74 | — | — | |
| SCHEMBL13982766 | 0.74 | — | — | |
| SCHEMBL14649909 | 0.71 | TEAD4 (0.37) | — | |
| SCHEMBL15727542 | 0.70 | — | — | |
| SCHEMBL22875547 | 0.70 | — | — | |
| SCHEMBL17874862 | 0.70 | MPO (0.35) | — | |
| SCHEMBL5552545 | 0.70 | CA1 (0.32) | — | |
| SCHEMBL19140806 | 0.70 | — | — | |
| SCHEMBL13562499 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114787136-A | Substituted benzimidazole carboxamides and their use in the treatment of medical disorders | 比亚尔R&D投资股份公司 | 2022-07-22 | — | — | CN | disclosed |
| US-9359380-B2 | DNA-PK inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140275059-A1 | DNA-PK INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-09-18 | — | — | US | disclosed |